| 2026-05-15 |
详情>>
内部人交易：
ARMEN GARO H股份增加4540.00股
|
| 2026-05-11 |
详情>>
股本变动：
变动后总股本4164.24万股
|
| 2026-05-11 |
详情>>
业绩披露：
2026年一季报每股收益1.03美元,归母净利润3917.20万美元,同比去年增长254.71%
|
| 2026-05-11 |
财报披露：
美东时间 2026-05-11 盘前发布财报
|
| 2026-04-30 |
股东大会：
将于2026-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Garo Armen and Jennifer Buell as Class II directors, for a term of three years expiring at the 2029 Annual Meeting of Stockholders.
2.To approve an amendment to our 2019 Employee Stock Purchase Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 150,000 shares to 200,000 shares.
3.To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan to increase the aggregate shares available for issuance by 5,000,000 shares.
4.To approve a one-time stock option exchange program under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan, with premium strike prices applicable to director and executive officer replacement options.
5.To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers for 2025 (Say-on-Pay).
6.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
7.To consider any other business as may properly come before the 2026 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2026-03-16 |
详情>>
业绩披露：
2025年年报每股收益0.00美元,归母净利润-10.1万美元,同比去年增长99.96%
|
| 2025-12-19 |
复牌提示：
2025-12-19 10:43:50 停牌，复牌日期 2025-12-19 10:48:50
|
| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.37美元,归母净利润1053.10万美元,同比去年增长105.80%
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益-2.03美元,归母净利润-5332.9万美元,同比去年增长53.66%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-1.03美元,归母净利润-2532万美元,同比去年增长59.12%
|
| 2025-04-30 |
股东大会：
将于2025-06-17召开股东大会
会议内容 ▼▲
- 1.To elect Brian Corvese and Timothy Wright as Class I directors, for a term of three years expiring at the 2028 Annual Meeting of Stockholders.
2.To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares.
3.To approve an amendment to our Amended and Restated Directors’ Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 63,750 shares to 88,750 shares.
4.To approve an amendment to our 2019 Employee Stock Purchase Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 100,000 shares to 150,000 shares.
5.To approve a one-time exchange of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan.
6.To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers.
7.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
8.To consider any other business as may properly come before the 2025 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2025-03-17 |
详情>>
业绩披露：
2024年年报每股收益-10.59美元,归母净利润-2.27亿美元,同比去年增长7.54%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-8.65美元,归母净利润-1.82亿美元,同比去年增长9.08%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-5.56美元,归母净利润-1.15亿美元,同比去年增长16.23%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-3.04美元,归母净利润-6194万美元,同比去年增长9.32%
|
| 2024-04-26 |
股东大会：
将于2024-06-11召开股东大会
会议内容 ▼▲
- 1.To elect Susan Hirsch as a Class III director, for a term of three years expiring at the 2027 Annual Meeting of Stockholders.
2.To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan.
3.To approve an amendment to our Amended and Restated Directors’ Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 38,750 shares to 63,750 shares.
4.To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers.
5.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
6.To consider any other business as may properly come before the 2024
|
| 2024-04-12 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2024-03-14 |
详情>>
业绩披露：
2023年年报每股收益-0.69美元,归母净利润-2.46亿美元,同比去年增长-11.66%
|
| 2024-02-26 |
股东大会：
将于2024-04-03召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding common stock at a ratio of 1-for-20.
2.To consider any other business as may properly come before Special Meeting or any postponement or adjournment of the meeting.
|
| 2023-04-28 |
股东大会：
将于2023-06-12召开股东大会
会议内容 ▼▲
- 1.To elect Garo H. Armen, Susan Hirsch and Ulf Wiinberg as Class II directors, each for a term of three years expiring at the 2026 Annual Meeting of Stockholders.
2.To approve an amendment to our 2019 Employee Stock Purchase Plan (as amended) to increase the number of shares of common stock authorized for issuance under such plan from 1,000,000 to 2,000,000.
3.To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers.
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
5.To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.
6.To consider any other business as may properly come before the 2023,Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2022-06-22 |
股东大会：
将于2022-08-04召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Amended and Restated Articles of Incorporation, as amended (the “Articles of Incorporation”), to increase the Company’s authorized shares of common stock from 400,000,000 to 800,000,000;
2.To consider any other business as may properly come before the Special Meeting or any postponement or adjournment of the meeting.
|
| 2022-04-29 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.To elect Brian Corvese and Timothy R. Wright as Class I directors, each for a term of three years expiring at the 2025 Annual Meeting of Stockholders.
2.To approve an amendment to our Amended and Restated Directors’ Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance under such plan from 575,000 to 775,000.
3.To approve an amendment to our 2019 Equity Incentive Plan (as amended) to increase the number of shares of common stock authorized for issuance under such plan from 26,000,000 to 41,000,000.
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
5.To consider any other business as may properly come before the 2022 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-15召开股东大会
会议内容 ▼▲
- 1.To elect Wadih Jordan and Allison M. Jeynes-Ellis as Class III directors, each for a term of three years expiring at the 2024 Annual Meeting of Stockholders.
2.To approve an amendment to our 2019 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance under such plan from 11,000,000 to 26,000,000.
3.To approve an amendment to our 2019 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance under such plan from 500,000 to 1,000,000.
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
5.To consider any other business as may properly come before the 2021 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2020-04-28 |
股东大会：
将于2020-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Garo H. Armen and Ulf Wiinberg as Class II directors, each for a term of three years expiring at the 2023 Annual Meeting of Stockholders.
2.To approve an amendment to our Amended and Restated Directors’ Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 425,000 shares to 575,000 shares.
3.To approve our 2019 Employee Stock Purchase Plan.
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
5.To approve, in a non-binding advisory vote, the compensation of the Company’s named executive officers.
6.To consider any other business as may properly come before the 2020 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2019-04-26 |
股东大会：
将于2019-06-19召开股东大会
会议内容 ▼▲
- 1.To elect Brian Corvese and Timothy R. Wright as Class I directors, each for a term of three years expiring at the 2022 Annual Meeting of Stockholders.
2.To approve an amendment to our Amended and Restated Certificate of Incorporation (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 240,000,000 to 400,000,000.
3.To approve our 2019 Equity Incentive Plan.
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
5.To consider any other business as may properly come before the 2019 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2018-04-26 |
股东大会：
将于2018-06-20召开股东大会
会议内容 ▼▲
- 1.To elect Wadih Jordan as a Class III director for a term of three years expiring at the 2021 Annual Meeting of Stockholders.
2.To approve an amendment to our Amended and Restated 2009 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance under such plan from 20,200,000 to 29,200,000.
3.To approve an amendment to our Director’s Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance under such plan from 325,000 to 425,000.
4.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.
5.To consider any other business as may properly come before the 2018 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|
| 2017-05-08 |
股东大会：
将于2017-06-28召开股东大会
会议内容 ▼▲
- 1. To elect Garo H. Armen, Ph.D. and Ulf Wiinberg as Class II directors, each for a term of three years expiring at the 2020 Annual Meeting of Stockholders.
2. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017.
3. To approve, in a non-binding advisory vote, the compensation of the Company’s named executive officers.
4. To recommend, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers.
5. To consider any other business as may properly come before the 2017 Annual Meeting of Stockholders or any postponement or adjournment of the meeting.
|